Skip to main content
Erschienen in: Indian Journal of Hematology and Blood Transfusion 3/2014

01.09.2014 | Case Report

Rare Case of Acquired Haemophilia and Lupus Anticoagulant

verfasst von: Devika Gupta, Tathagat Chatterjee, Ajay Sharma, Prosenjit Ganguli, Satyaranjan Das, Sanjeevan Sharma

Erschienen in: Indian Journal of Hematology and Blood Transfusion | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Acquired haemophilia or factor VIII (FVIII) deficiency, caused by FVIII inhibitor antibodies, is a very rare condition that commonly results in severe haemorrhagic complications. We report a case of acquired haemophilia presenting with multiple bluish patches affecting face, neck, upper & lower limbs, history of gum bleeding and left knee haemarthrosis. The patient was found to have acquired FVIII inhibitor and lupus anticoagulant (LAC). The simultaneous presence of LAC and FVIII inhibitor is exceedingly rare. The differentiation between these two conditions is crucial, because both result in a prolongation of the activated partial thromboplastin time test, which does not correct when mixed with the plasma of a normal control; however, the clinical manifestations range from thrombosis in the presence of LAC to massive haemorrhage with FVIII inhibitors.
Literatur
1.
Zurück zum Zitat Gawryl MS, Hoyer LW (1982) Inactivation of factor VIII coagulant activity by two different types of human antibodies. Blood 60:1103–1109PubMed Gawryl MS, Hoyer LW (1982) Inactivation of factor VIII coagulant activity by two different types of human antibodies. Blood 60:1103–1109PubMed
2.
Zurück zum Zitat Saxena R, Mishra DK, Kashyap R, Choudhry VP, Mahapatra M, Bhargava M (2000) Acquired haemophilia––a study of ten cases. Haemophilia 6:78–83PubMedCrossRef Saxena R, Mishra DK, Kashyap R, Choudhry VP, Mahapatra M, Bhargava M (2000) Acquired haemophilia––a study of ten cases. Haemophilia 6:78–83PubMedCrossRef
3.
Zurück zum Zitat Sahud MA (2000) Factor VIII inhibitors. Laboratory diagnosis of inhibitors. Semin Thromb Hemost 26:195–203PubMedCrossRef Sahud MA (2000) Factor VIII inhibitors. Laboratory diagnosis of inhibitors. Semin Thromb Hemost 26:195–203PubMedCrossRef
4.
Zurück zum Zitat Saxena R, Dhot PS, Saraya AK, Singh H, Malhotra OP (1993) Simultaneous occurrence of factor VIIIC inhibitor and lupus anticoagulant. Am J Hematol 42:232–233PubMedCrossRef Saxena R, Dhot PS, Saraya AK, Singh H, Malhotra OP (1993) Simultaneous occurrence of factor VIIIC inhibitor and lupus anticoagulant. Am J Hematol 42:232–233PubMedCrossRef
5.
Zurück zum Zitat Brings HA, Waas JK, McCrae KR, Baele HR, Goldstone J (2002) Successful management of life-threatening hemorrhage in a patient with synchronous lupus anticoagulant and factor VIII inhibitor. J Vasc Surg 36:853–855PubMedCrossRef Brings HA, Waas JK, McCrae KR, Baele HR, Goldstone J (2002) Successful management of life-threatening hemorrhage in a patient with synchronous lupus anticoagulant and factor VIII inhibitor. J Vasc Surg 36:853–855PubMedCrossRef
6.
Zurück zum Zitat Jennings I, Kitchen S, Woods TA et al (1997) Potentially clinically important inaccuracies in testing for the lupus anticoagulant:an analysis of results from three surveys of the UK National External Quality Assessment Scheme (NEQAS) for blood coagulation. Thromb Haemost 77:934–937PubMed Jennings I, Kitchen S, Woods TA et al (1997) Potentially clinically important inaccuracies in testing for the lupus anticoagulant:an analysis of results from three surveys of the UK National External Quality Assessment Scheme (NEQAS) for blood coagulation. Thromb Haemost 77:934–937PubMed
7.
Zurück zum Zitat Sahud MA, Pratt KP, Zhukov O, Qu K (2007) Thompson ar. ELISA system for detection of immune responses to FVIII: a study of 246 samples and correlation with the Bethesda assay. Haemophilia 13:317–322PubMedCrossRef Sahud MA, Pratt KP, Zhukov O, Qu K (2007) Thompson ar. ELISA system for detection of immune responses to FVIII: a study of 246 samples and correlation with the Bethesda assay. Haemophilia 13:317–322PubMedCrossRef
9.
Zurück zum Zitat Green D, Lechner K (1981) A survey of 215 non-hemophilic patients with inhibitors to factor VIII. Thromb Haemost 45:200–203PubMed Green D, Lechner K (1981) A survey of 215 non-hemophilic patients with inhibitors to factor VIII. Thromb Haemost 45:200–203PubMed
10.
Zurück zum Zitat Sallah S, Wan JY (2001) Inhibitors against factor VIII in patients with cancer. Analysis of 41 patients. Cancer 91:1067–1074PubMedCrossRef Sallah S, Wan JY (2001) Inhibitors against factor VIII in patients with cancer. Analysis of 41 patients. Cancer 91:1067–1074PubMedCrossRef
11.
Zurück zum Zitat Kasper CK, Pool JG (1975) Letter: measurement of mild factor VIII inhibitors in Bethesda units. Thromb Diath Haemorrh 34:875–876PubMed Kasper CK, Pool JG (1975) Letter: measurement of mild factor VIII inhibitors in Bethesda units. Thromb Diath Haemorrh 34:875–876PubMed
12.
Zurück zum Zitat Schulman S (2000) Continuous infusion of recombinant factor VIIa in haemophilic patients with inhibitors: safety, monitoring, and cost effectiveness. Semin Thromb Haemost 26(4):421–424CrossRef Schulman S (2000) Continuous infusion of recombinant factor VIIa in haemophilic patients with inhibitors: safety, monitoring, and cost effectiveness. Semin Thromb Haemost 26(4):421–424CrossRef
14.
Zurück zum Zitat Franchini M, Tagliaferri A, Mannucci PM (2007) The management of haemophilia in elderly patients. Clin Interv Aging 2:361–368PubMedCentralPubMed Franchini M, Tagliaferri A, Mannucci PM (2007) The management of haemophilia in elderly patients. Clin Interv Aging 2:361–368PubMedCentralPubMed
Metadaten
Titel
Rare Case of Acquired Haemophilia and Lupus Anticoagulant
verfasst von
Devika Gupta
Tathagat Chatterjee
Ajay Sharma
Prosenjit Ganguli
Satyaranjan Das
Sanjeevan Sharma
Publikationsdatum
01.09.2014
Verlag
Springer India
Erschienen in
Indian Journal of Hematology and Blood Transfusion / Ausgabe 3/2014
Print ISSN: 0971-4502
Elektronische ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-012-0204-5

Weitere Artikel der Ausgabe 3/2014

Indian Journal of Hematology and Blood Transfusion 3/2014 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.